Please login to the form below

Not currently logged in
Email:
Password:

Vical

This page shows the latest Vical news and features for those working in and with pharma, biotech and healthcare.

Genital herpes vaccine candidate heads for human studies

Genital herpes vaccine candidate heads for human studies

Last year, Vical abandoned its VCL-HB01 candidate for HSV-2 infections after it failed a mid-stage clinical trial.

Latest news

More from news
Approximately 4 fully matching, plus 9 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Oncosec

OncoSec is a clinical-stage biotechnology company focused on developing cytokine-based intratumoral immunotherapies to stimulate the body's immune system to target...

Latest intelligence

Theodora Harold
A snapshot of Crescendo Biologics
PME talks to CEO Theodora Harold...
eyeforpharma Marketing and Customer Innovation Europe
By Richard Springham...
US Drug pricing
The Golden Goose
Why it’s so hard for the US to curb runaway drug prices...

Infographics